Mean platelet volume in Behçet's disease

Aktuelle Rheumatologie

Volumn 33, Issue 4, 2008, Pages 217-220

  Karabudak, O ^a   Nalbant, Selim ^a   Sahan, B ^a   Unal, M ^a   Ersanli, D ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Beh et's disease; Mean platelet volume

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; AZATHIOPRINE; C REACTIVE PROTEIN; COLCHICINE; CORTICOSTEROID; INFLIXIMAB;

ADULT; ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE VOLUME;

EID: 54749094364     PISSN: 0341051X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1027205     Document Type: Article

References (17)

1. Broadley AJ, Gapper P, Schmitt M et al. Supine rest reduces platelet activation and aggregation. Platelets 2003; 14: 3-7
2. Dalby Kristensen S, Milner PC, Martin JF. Bleeding time and platelet volume in acute myocardial infarction - a 2 year follow-up study. Thromb Hemost 1988; 59: 353-356
3. Endler G, Klimesch A, Sunder-Plassmann H et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2002; 117: 399-404
4. Espinosa G, Cervera R, Reverter JC et al. Vascular involvement in Behçet's disease: Relation with thrombophilic factors, coagulation activation, and thrombomodulin. Am J Med 2002; 112: 37-43
5. Kiliçli-Çamur N, Demirtunç R, Konuralp C et al. Could mean platelet volume be a predictive marker for acute myocardial infarction? Med Sci Monit 2005; 11: CR387-cr392
6. Krause I, Rosen Y, Kaplan I et al. Recurrent aphthous stomatitis in Behcet's disease: clinical features and correlation with systemic disease expression and severity. J Oral Pathol Med 1999; 28: 193-196
7. Mathur A, Robinson MS, Cotton J et al. Platelet reactivity in acute coronary syndromes: evidence for differences in platelet behaviour between unstable angina and myocardial infarction. Thromb Haemost 2001; 85: 989-994
8. Nadar SK, Blann AD, Kamath S et al. Platelet indexes in relation to target organ damage in high-risk hypertensive patients. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol 2004; 44: 415-422
9. Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 2002; 13: 301-306
10. Sakane T, Takeno M, Suzuki N et al. Behcet's disease. N Engl J Med 1999; 3: 1284-1291
11. Server A, Özcan MA, Ateş H et al. Circulated activated platelets and increased platelet reactivity in patients with Behçet's disease. Clin Appl Thromb Hemost 2006; 12: 451-457
12. Study Group for Behçet's disease. Criteria for diagnosis of Behçet's disease. International Lancet 1990; 335: 1078
13. Toplak H, Wascher TC. Influence of weight reduction on platelet volume: different effects of a hypocaloric diet and a very low calorie diet. Eur J Clin Invest 1994; 24: 778-780
14. Tsiara S, Elisaf M, Jagroop IA et al. Platelets as predictors of vascular risk: is there a practical index of platelet activity? Clin Appl Thromb Hemost 2003; 9: 177-190
15. Wilson AP, Efthimiou J, Betteridge DJ. Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndrome. Eur J Clin Invest 1988; 18: 410-414
16. Wu KK. Platelet activation and carotid arterial atherothrombosis. In: Gotto AM, Lenfant C, Paoletti R, Catapano AL, Jackson AS (ed). Multiple Risk Factors in Cardiovascular Disease. Dordrecht, Netherlands: Kluwer Academic Publisher, 1998: 61-65
17. Yurdakul S, Hamuryudan V, Yazici H. Behcet syndrome. Curr Opin Rheumatol 2004; 16: 38-42